Getting to the Heart of the Matter: Medscape Education at AHA 2024!
November 12, 2024 | AHA24, CME, Cardiovascular, Symposia, cardiology, cardiomyopathy, hypertension
Come join Medscape Education at the American Heart Association (AHA) 2024 Scientific Sessions in Chicago, IL, from November 16-18 — a dynamic event packed with cutting-edge cardiology education that you won’t want to miss! 🚀 This year, we are hosting 6 highly interactive symposia, each designed to elevate the learner’s expertise and knowledge, while diving deep into the latest advancements in Cardiology!
Key Symposia at AHA 2024
Our carefully curated symposia cover a broad range of critical cardiology topics, ensuring that attendees are well-equipped to tackle emerging challenges in cardiovascular health. Here’s a preview of what you can expect:
Saturday, November 16
1. Proactive Cardiovascular Protection Along the Cardiac Continuum: Understanding Risk to Optimize Prevention: Explore cutting-edge strategies in proactive cardiovascular protection. By understanding the full spectrum of cardiovascular risk, we can improve prevention efforts and outcomes.
2. Navigating New Paradigms in Thrombosis Management: Gameshow Evaluation of Evolving Anticoagulation Approaches: This interactive “gameshow” format, is designed to engage learners in the latest advancements in anticoagulation therapies and their role in thrombosis management.
Sunday, November 17
3. From Challenge to Control: Innovative Therapies in Hypertension Management: Discover the recent innovations in the treatment of hypertension, including novel therapies and management strategies aimed at overcoming the challenges faced by clinicians.
4. Transforming Perspectives on Transthyretin Amyloid Cardiomyopathy: Insights Into Evolving Advances: Learn about recent advances in diagnostics and treatment options for Transthyretin amyloid cardiomyopathy.
5. Heart Failure with Preserved or Mildly Reduced Ejection Fraction: Impacting Health Outcomes with Nonsteroidal MRAs: Explore how the use of nonsteroidal mineralocorticoid receptor antagonists (MRAs) can improve outcomes in patients with heart failure, particularly those with preserved or mildly reduced ejection fraction.
6. Hypertrophic Cardiomyopathy Masterclass: Rapid Fire Case Consults: In this hands-on masterclass, we will work through real-life hypertrophic cardiomyopathy (HCM) cases, providing expert insights and interactive discussions on the latest diagnostic and therapeutic approaches.
These sessions are more than just symposia— they offer an opportunity to engage with leading cardiology experts, participate in thought-provoking discussions, and gain insights that can immediately enhance clinical practice. Don’t miss this chance to take your cardiology practice to the next level. Register today and secure your spot for these educational opportunities!
Additionally, be sure to join us for a highly anticipated oral presentation on “Echocardiography in Hypertrophic Cardiomyopathy: Virtual CME Advances Physician Knowledge and Confidence,” November 18th from 9:40 am – 9:45 am, during the Imaging and Technologies in Heart Failure digital poster session.
For more information on Cardiology Education, contact David Anderson.
We look forward to seeing you at AHA 2024 in Chicago, IL!
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care
The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...
Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden
Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...
#ShortenTheJourney
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...
Why We Must Stop Normalizing the “Pregnancy Itch”
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...
The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health
A February Focus on the Heart While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....
AI, Agility, and Connected Impact at Alliance 2026
Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...
Why Sleep Health is the Missing Link in Women’s Wellness
While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...
The Heart and Mouth Connection Every Woman Needs to Know
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...
Uncovering Inequities in Alzheimer’s Disease Screening and Care
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...
Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.